Skip to main content
. 2022 Aug 5;11(15):2421. doi: 10.3390/cells11152421

Figure 6.

Figure 6

High tumor miR-187-3p levels were correlated with postoperative recurrence: (A) Tumor miR-187-3p levels in CRC patients with no recurrence (n = 35) or with recurrent disease (n = 11) within 5 years following R0 resection for stage I–III CRC. (B) Disease-free survival curves for CRC patients with high or low tumor miR-187-3p levels.